GoldMining Inc
GOLD
Shopify Inc
SHOP
Celestica Inc
CLS
4
GoldMoney Inc
XAU
5
Andlauer Healthcare Group Inc
AND
CA Stock MarketDetailed Quotes
IZO Izotropic Corp
- 0.235
- +0.010+4.44%
15min DelayMarket Closed Apr 25 15:55 ET
13.35MMarket Cap-5.88P/E (TTM)
0.260High0.220Low31.01KVolume0.220Open0.225Pre Close7.05KTurnover0.47052wk High0.06%Turnover Ratio56.80MShares0.03552wk Low-0.04EPS TTM12.92MFloat Cap1.560Historical HighLossP/E (Static)55.00MShs Float0.035Historical Low-0.03EPS LYR17.78%Amplitude--Dividend TTM-2.80P/B1Lot Size--Div YieldTTM
Izotropic Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -189.99%-208.3K | 80.33%-82.59K | -39.18%-104.57K | 81.83%-593.57K | 88.63%-26.76K | 93.18%-71.83K | 48.23%-419.84K | 93.56%-75.13K | 31.44%-3.27M | 87.67%-235.43K |
| Net income from continuing operations | -93.31%-575.18K | 56.27%-346.59K | -166.76%-1.26M | 72.42%-1.56M | 100.01%165 | 85.09%-297.54K | 42.79%-792.64K | 54.07%-471.35K | 14.93%-5.66M | 23.63%-1.25M |
| Depreciation and amortization | -13.84%12.58K | -10.39%13.54K | -13.67%12.55K | 91.28%59.07K | 3.25%14.82K | 40.02%14.6K | 348.89%15.11K | 432.10%14.54K | 349.40%30.88K | 6,338.57%14.36K |
| Remuneration paid in stock | --0 | --0 | --0 | -93.01%80.28K | --0 | -100.82%-7.04K | -9.79%47.2K | -32.76%40.12K | 7.27%1.15M | -73.14%179.98K |
| Other non cashItems | -124.46%-15.3K | -96.83%2.02K | 990.94%706.46K | 108.93%615.11K | 486.65%424.25K | -19.35%62.55K | -23.00%63.55K | 4.44%64.76K | 111.30%294.41K | --72.32K |
| Change In working capital | 137.53%369.61K | 0.62%248.45K | 56.70%433.75K | -76.85%213.33K | -161.96%-466.01K | 8,635.66%155.61K | -43.40%246.92K | 204.34%276.8K | 36.69%921.29K | 169.84%752.15K |
| -Change in receivables | -99.28%118 | -728.95%-5.04K | --0 | -51.87%13.41K | 710.80%6.56K | 266.24%16.4K | -112.92%-608 | -145.33%-8.95K | 957.92%27.86K | -155.39%-1.07K |
| -Change in prepaid assets | 84.77%-12.93K | -67.19%14.28K | -63.47%862 | -95.03%10.63K | -44.48%49.63K | -492.85%-84.87K | -68.67%43.51K | 21,354.55%2.36K | -4.97%213.96K | 128.47%89.38K |
| -Change in payables and accrued expense | 70.67%382.42K | 17.25%239.21K | 52.75%432.89K | -72.14%189.29K | -178.66%-522.19K | 2,696.29%224.07K | -30.28%204.02K | 199.43%283.39K | 52.29%679.48K | 186.77%663.85K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -189.99%-208.3K | 80.33%-82.59K | -39.18%-104.57K | 81.83%-593.57K | 88.63%-26.76K | 93.18%-71.83K | 48.23%-419.84K | 93.56%-75.13K | 31.44%-3.27M | 87.67%-235.43K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1.14K | 0 | 0 | 0 | -49.35%-36.18K | -183.21%-6.39K | ||||
| Net PPE purchase and sale | ---1.14K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -49.35%-36.18K | -183.21%-6.39K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---1.14K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -49.35%-36.18K | -183.21%-6.39K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,986.04%317.35K | -77.49%92.55K | 112.56%168.67K | -70.96%468.18K | -6.82%-11.23K | -101.88%-11K | 38.59%411.05K | -89.32%79.35K | -37.53%1.61M | -100.46%-10.51K |
| Net issuance payments of debt | 151.43%5.66K | 80.97%-11.66K | -6.41%-11.33K | -432.46%-94.15K | -6.82%-11.23K | -53.30%-11K | ---61.28K | ---10.65K | -100.86%-17.68K | -100.51%-10.51K |
| Net common stock issuance | --244.9K | --0 | --180K | -60.86%710.33K | --0 | --0 | 1,177.87%710.33K | --0 | 241.63%1.81M | --0 |
| Cash dividends paid | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 |
| Interest paid (cash flow from financing activities) | --0 | ---- | ---- | 19.78%-148K | --0 | --0 | ---- | ---- | ---184.5K | --0 |
| Net other financing activities | --66.79K | ---- | ---- | ---- | ---- | ---- | ---- | 1,100.00%90K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,986.04%317.35K | -77.49%92.55K | 112.56%168.67K | -70.96%468.18K | -6.82%-11.23K | -101.88%-11K | 38.59%411.05K | -89.32%79.35K | -37.53%1.61M | -100.46%-10.51K |
| Net cash flow | ||||||||||
| Beginning cash position | -26.80%116.67K | -39.98%102.05K | -76.70%38.6K | -91.08%165.69K | -81.08%79.23K | -82.44%159.38K | -88.08%170.04K | -91.08%165.69K | -54.31%1.86M | -71.71%418.75K |
| Current changes in cash | 230.28%107.91K | 213.25%9.96K | 1,419.27%64.1K | 92.58%-125.39K | 84.94%-37.99K | 83.05%-82.83K | 98.31%-8.79K | 100.98%4.22K | 23.43%-1.69M | -167.02%-252.33K |
| Effect of exchange rate changes | -241.86%-3.79K | 349.20%4.66K | -569.57%-648 | -121.89%-1.69K | -256.22%-2.64K | 11,721.74%2.67K | ---1.87K | --138 | ---763 | ---740 |
| End cash Position | 178.67%220.78K | -26.80%116.67K | -39.98%102.05K | -76.70%38.6K | -76.70%38.6K | -81.08%79.23K | -82.44%159.38K | -88.08%170.04K | -91.08%165.69K | -91.08%165.69K |
| Free cash from | -191.58%-209.44K | 80.33%-82.59K | -39.18%-104.57K | 82.03%-593.57K | 88.93%-26.76K | 93.30%-71.83K | 48.56%-419.84K | 93.59%-75.13K | 31.03%-3.3M | 87.29%-241.82K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.